Editor’s pick: Excelsior Sciences
Nature Biotechnology, Published online: 03 August 2026; doi:10.1038/s41587-026-03249-3 Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Excelsior Sciences is developing a closed-loop system for drug discovery using carbon building bloccs.
We haven't written up this one. Nature Biotechnology has the full story — the link below goes straight to it.
